A detailed history of Klp Kapitalforvaltning As transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 1,527,558 shares of BMY stock, worth $71.5 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,527,558
Previous 1,433,058 6.59%
Holding current value
$71.5 Million
Previous $66.3 Million 3.85%
% of portfolio
0.28%
Previous 0.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$43.31 - $48.98 $4.09 Million - $4.63 Million
94,500 Added 6.59%
1,527,558 $68.9 Million
Q2 2025

Jul 23, 2025

BUY
$44.12 - $59.6 $3.86 Million - $5.22 Million
87,600 Added 6.51%
1,433,058 $66.3 Million
Q1 2025

May 06, 2025

BUY
$53.9 - $63.11 $3.22 Million - $3.77 Million
59,700 Added 4.64%
1,345,458 $82.1 Million
Q4 2024

Feb 11, 2025

BUY
$51.92 - $59.94 $66.8 Million - $77.1 Million
1,285,758 New
1,285,758 $72.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.